JENNIFER SOMMER: Open Payments
NPI 1386199396 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 68 payments from 7 companies in 2025. Trend: 2023 $37 · 2024 $1,641 · 2025 $1,294
Food & beverage: $1,294
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 24 | $456 |
| Gilead Sciences, Inc. | 16 | $334 |
| Merck Sharp & Dohme LLC | 9 | $200 |
| ABBVIE INC. | 14 | $179 |
| Insmed, Inc. | 3 | $76 |
| Theratechnologies Inc. | 1 | $29 |
| Melinta Therapeutics, LLC | 1 | $20 |
Products named: APRETUDE, DOVATO, CABENUVA, PIFELTRO, Arikayce, ZERBAXA, AVYCAZ, EMBLAVEO.
Industry payments across NC — which companies pay providers there.
